Anais de Pesquisa Clínica e Laboratorial

  • ISSN: 2386-5180
  • Índice h do diário: 17
  • Pontuação de citação de diário: 6.26
  • Fator de impacto do periódico: 5.31
Indexado em
  • Genamics JournalSeek
  • Infraestrutura Nacional de Conhecimento da China (CNKI)
  • CiteFactor
  • Diretório de Indexação de Periódicos de Pesquisa (DRJI)
  • publons
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEU
  • Laboratórios secretos do mecanismo de pesquisa
Compartilhe esta página

Abstrato

Impact of Fingolimod on Multiple Sclerosis

Mamatha Dereddy*

Fingolimod could be a sphingosine-1-phosphate receptor modulator that sequesters liquid body substanceocytes in lymph nodes preventing them from conducive to a reaction reaction. it's been reportable to scale back the speed of relapses in relapsing-remitting disseminated multiple sclerosis by or so common fraction over a biennial amount. Fingolimod was shown to be effective in experimental reaction rubor, six AN animal model of disseminated multiple sclerosis (MS), and later investigated in 2 clinical trial clinical trials for relapsingremitting (RR)MS. seven In these trials, fingolimod was incontestable to be a secure and effective drug.